Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Freeman OD, FAAO, FCOVD
Paul B. Freeman OD, FAAO, FCOVD Editor-in-Chief
Weiye Li MD, PhD
Weiye Li MD, PhD Advisory Board
Robert N. Kleinstein OD, MPH, PhD Advisory Board
See All Experts
Published in Eye Care

News · October 14, 2022

AAO 2022: Faricimab Safe, Effective for Neovascular Age-Related Macular Degeneration

Two phase 3 trials show durable improvement with fewer injections over 48 weeks

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated